We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $71.2B Turnover 9.3%
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$53.3B
AUM Growth
-$1.27B
Cap. Flow
-$2.12B
Cap. Flow %
-3.97%
Top 10 Hldgs %
31.1%
Holding
948
New
33
Increased
275
Reduced
575
Closed
17
Avg Time Held
5 years
Top 10 Avg Time Held
3.5 years
Top 20 Avg Time Held
3.3 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$319M
2
EQIX icon
Equinix
EQIX
+$141M
3
AVGO icon
Broadcom
AVGO
+$50M
4
SPOT icon
Spotify
SPOT
+$43.3M
5
SHW icon
Sherwin-Williams
SHW
+$30.8M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$203M
2
AAPL icon
Apple
AAPL
+$179M
3
TT icon
Trane Technologies
TT
+$118M
4
AMZN icon
Amazon
AMZN
+$86.8M
5
CBRE icon
CBRE Group
CBRE
+$86.2M

Sector Composition

Rank Sector Weight
1 Technology 31.36%
2 Healthcare 14.24%
3 Financials 10.98%
4 Consumer Discretionary 10.46%
5 Communication Services 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
STRO icon
926
Sutro Biopharma
STRO
$190M
$128K ﹤0.01%
6,939
– –
2023 Q4
4 quarters
ALXO icon
927
ALX Oncology
ALXO
$138M
$111K ﹤0.01%
66,211
– –
2023 Q4
4 quarters
MURA icon
928
DELISTED
Mural Oncology
MURA
$104K ﹤0.01%
32,342
– –
2023 Q4
4 quarters
NKTX icon
929
Nkarta
NKTX
$138M
$72.2K ﹤0.01%
28,988
– –
2023 Q4
4 quarters
AFMD icon
930
DELISTED
Affimed
AFMD
$24.8K ﹤0.01%
20,862
– –
2023 Q4
4 quarters
ACLX icon
931
DELISTED
Arcellx
ACLX
– –
-50,796
Closed -$4.24M –
APLS icon
932
DELISTED
Apellis Pharmaceuticals
APLS
– –
-236,724
Closed -$6.83M –
BBWI icon
933
Bath & Body Works
BBWI
$4.12B
– –
-8,974
Closed -$284K –
COUR icon
934
Coursera
COUR
$1.35B
– –
-191,396
Closed -$1.52M –
EXEL icon
935
Exelixis
EXEL
$15.6B
– –
-314,537
Closed -$8.16M –
EXLS icon
936
EXL Service
EXLS
$5.93B
– –
-73,847
Closed -$2.82M –
FSK icon
937
FS KKR Capital
FSK
$2.97B
– –
-81,732
Closed -$1.61M –
HPP icon
938
Hudson Pacific Properties
HPP
$606M
– –
-4,058
Closed -$136K –
IQ icon
939
iQIYI
IQ
$948M
– –
-93,333
Closed -$267K –
OCSL icon
940
Oaktree Specialty Lending
OCSL
$1.04B
– –
-44,336
Closed -$726K –
SITE icon
941
SiteOne Landscape Supply
SITE
$4.12B
– –
-101,465
Closed -$15.3M –
SVC
942
Service Properties Trust
SVC
$802M
– –
-6,784
Closed -$155K –
VRNS icon
943
Varonis Systems
VRNS
$5.44B
– –
-33,768
Closed -$1.91M –
VRNT icon
944
DELISTED
Verint Systems
VRNT
– –
-448,523
Closed -$11.4M –
NBIS icon
945
Nebius Group N.V.
NBIS
$51.2B
$0 ﹤0.01%
53,088
-23,353
-31% -$569K
2017 Q3
29 quarters
ZBIO icon
946
Zenas BioPharma
ZBIO
$1.66B
– –
-75,100
Closed -$1.27M –
CTLT icon
947
DELISTED
CATALENT, INC.
CTLT
– –
-70,559
Closed -$4.27M –
MRO icon
948
DELISTED
Marathon Oil Corporation
MRO
– –
-170,327
Closed -$4.5M –

Similar funds

Aberdeen Group's Q4 2024 Portfolio in Review

As of Q4 2024, Aberdeen Group held 948 positions worth $53.3B, down 2.3% from $54.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Aberdeen Group withdrew a net $2.12B in Q4 2024, closing 17 positions and reducing 575 holdings. Its most notable exit was SiteOne Landscape Supply, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Aberdeen Group opened a new position in Aptiv worth $30.4M.

  • Aberdeen Group's largest Q4 2024 buy was Aptiv: 502,429 shares worth $30.4M.
  • Aberdeen Group added most to Microsoft in Q4 2024, an estimated $319M increase.
  • Aberdeen Group's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $203M.
  • Aberdeen Group fully exited SiteOne Landscape Supply in Q4 2024, selling an estimated $15.3M.
  • Aberdeen Group's ten largest holdings make up 31% of its $53.3B portfolio in Q4 2024.
  • Aberdeen Group opened 33 new positions and closed 17 in Q4 2024.
  • Aberdeen Group's portfolio value fell 2.3% quarter-over-quarter to $53.3B.

Based on Aberdeen Group's 13F filing for Q4 2024, filed 24 Jan 2025.